Silver Rises Sharply; Chicago PMI Surges In December
Benzinga (Tue, 30-Dec 12:03 PM ET)
European Patent Expands Autonomix Medical’s Precision Nerve Therapy Platform
Market Chameleon (Tue, 30-Dec 4:52 AM ET)
Globe Newswire (Tue, 30-Dec 8:30 AM ET)
Globe Newswire (Tue, 23-Dec 8:45 AM ET)
Globe Newswire (Thu, 18-Dec 8:30 AM ET)
Globe Newswire (Wed, 26-Nov 8:45 AM ET)
Globe Newswire (Tue, 18-Nov 8:30 AM ET)
Market Chameleon (Mon, 17-Nov 4:52 AM ET)
Globe Newswire (Mon, 17-Nov 8:00 AM ET)
Autonomix Medical Inc is a development-stage medical device development company focused on advancing technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.
Autonomix Medical trades on the NASDAQ stock market under the symbol AMIX.
As of December 30, 2025, AMIX stock price climbed to $0.58 with 75,301,217 million shares trading.
AMIX has a beta of 1.61, meaning it tends to be more sensitive to market movements. AMIX has a correlation of 0.08 to the broad based SPY ETF.
AMIX has a market cap of $4.01 million. This is considered a Sub-Micro Cap stock.
The top ETF exchange traded funds that AMIX belongs to (by Net Assets): VXF.
AMIX has underperformed the market in the last year with a price return of -82.4% while the SPY ETF gained +16.7%. AMIX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -45.3% and -12.5%, respectively, while the SPY returned +3.8% and +1.2%, respectively.
AMIX support price is $.50 and resistance is $.57 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AMIX shares will trade within this expected range on the day.
